+ |
CDKL5 | down-regulates activity
phosphorylation
|
AMPH |
0.369 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-245881 |
Ser293 |
PAPARPRsPSQTRKG |
Mus musculus |
|
pmid |
sentence |
23651931 |
This 120-kDa protein was identified as amphiphysin 1 (Amph1) by LC-MS/MS analysis, and the site of phosphorylation by CDKL5 was determined to be Ser-293.| The phosphorylation mimic mutants, Amph1(S293E) and Amph1(S293D), showed significantly reduced affinity for endophilin, a protein involved in synaptic vesicle endocytosis |
|
Publications: |
1 |
Organism: |
Mus Musculus |
+ |
CDKL5 |
phosphorylation
|
LRRC4C |
0.44 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-192035 |
Ser631 |
PLLIRMNsKDNVQET |
Homo sapiens |
|
pmid |
sentence |
22922712 |
Cdkl5 binds and phosphorylates the cell adhesion molecule ngl-1. This phosphorylation event ensures a stable association between ngl-1 and psd95. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
CDKL5 | up-regulates activity
phosphorylation
|
CDKL5 |
0.2 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-262289 |
Thr169 |
EGNNANYtEYVATRW |
in vitro |
|
pmid |
sentence |
16935860 |
Furthermore, we show that CDKL5 can self-associate and mediate the phosphorylation of its own TEY (Thr-Glu-Tyr) motif. |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-245876 |
Tyr171 |
NNANYTEyVATRWYR |
in vitro |
|
pmid |
sentence |
16935860 |
Furthermore, we show that CDKL5 can self-associate and mediate the phosphorylation of its own TEY (Thr-Glu-Tyr) motif. |
|
Publications: |
2 |
Organism: |
In Vitro |
Pathways: | Rett syndrome |
+ |
MEF2C | up-regulates quantity by expression
transcriptional regulation
|
CDKL5 |
0.358 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-254031 |
|
|
Homo sapiens |
|
pmid |
sentence |
20513142 |
Mutations in MEF2C from the 5q14.3q15 microdeletion syndrome region are a frequent cause of severe mental retardation and diminish MECP2 and CDKL5 expression|In these patients we found diminished MECP2 and CDKL5 expression in vivo, and transcriptional reporter assays indicated that MEF2C mutations diminish synergistic transactivation of E-box promoters including that of MECP2 and CDKL5. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Pathways: | Rett syndrome |
+ |
CDKL5 |
phosphorylation
|
MECP2 |
0.621 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-264702 |
|
|
in vitro |
|
pmid |
sentence |
16935860 |
Phosphorylation assays performed with the wild-type protein confirm its capability to mediate the modification of MeCP2 in vitro, whereas Rett missense mutations within the conserved catalytic domain abrogate or significantly impair the enzymatic activity |
|
Publications: |
1 |
Organism: |
In Vitro |
Pathways: | Rett syndrome |